Compound ID | 1871
Synonym(s): CP-45,899
Class: Beta-lactamase inhibitor (penicillanic acid sulfone)
| Details of activity: | Binds irreversibly to beta-lactamases, mainly class A enzymes. No intrinsic antibacterial activity except some antibacterial activity against Acinetobacter |
| Combined with other compounds: | Yes |
| Description: | Streptomyces natural product. Only available as a combination product, oral and parenteral application |
| Institute where first reported: | Pfizer |
| Year first mentioned: | 1978 |
| Highest developmental phase: | Approved by FDA in 1986 |
| Development status: | Approved, off-patent |
| Chemical structure(s): | |||||||||||
|
|
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/130313 |
| Guide to Pharmacology: | sulbactam |
| Citations: |
|